rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

David Moatazedi

Director and Officer

Company insider

Files Form 4 as: Director and Officer, Evolus; Director, Biomerica; Director, Vyome Holdings.

Every Form 4 they filed

In numbers

Trades disclosed
80
Buys
1
Sells
30
Bought
$32K
Sold
$18.5M
Companies
3
Companies where not an officer
2
First trade
13 Mar 2017
Last trade
2 Sep 2026
Last filed
4 Sep 2026

Companies traded

Where they are an officer
EOLS EvolusDirector, Officer · Biotechnology · last 2 Sep 20260 buys · 30 sells
Everywhere else they filed: board seats, 10% stakes, other companies
BMRA BiomericaDirector · Diagnostics & Labs · last 26 Aug 20261 buy · 0 sells
HIND Vyome HoldingsDirector · Biotechnology · last 23 Jul 20190 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
201Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
2 Sep 2026filed 4 Sep 2026EOLS EvolusBiotechnologySEC FORM 4 Sold$950K105,108 at $9.04filing
2 Sep 2026filed 4 Sep 2026EOLS EvolusBiotechnologySEC FORM 4 Sold$950K105,108 at $9.04filing
26 Aug 2026filed 27 Aug 2026BMRA BiomericaDiagnostics & LabsSEC FORM 4 Bought$16K10,000 at $1.60filing
26 Aug 2026filed 27 Aug 2026BMRA BiomericaDiagnostics & LabsSEC FORM 4 Bought$16K10,000 at $1.60filing
20 Mar 2026filed 20 Mar 2026EOLS EvolusBiotechnologySEC FORM 4 Sold$65K13,669 at $4.75filing
20 Mar 2026filed 20 Mar 2026EOLS EvolusBiotechnologySEC FORM 4 Sold$65K13,669 at $4.75filing
17 Mar 2026filed 18 Mar 2026EOLS EvolusBiotechnologySEC FORM 4 Sold$571K116,720 at $4.89filing
17 Mar 2026filed 18 Mar 2026EOLS EvolusBiotechnologySEC FORM 4 Sold$571K116,720 at $4.89filing
16 Mar 2026filed 18 Mar 2026EOLS EvolusBiotechnologySEC FORM 4 Code M—67,489 at $0.00filing
16 Mar 2026filed 18 Mar 2026EOLS Evolusoption or derivative · BiotechnologySEC FORM 4 Code M—67,489 at $0.00filing
16 Mar 2026filed 18 Mar 2026EOLS Evolusoption or derivative · BiotechnologySEC FORM 4 Code M—67,489 at $0.00filing
16 Mar 2026filed 18 Mar 2026EOLS EvolusBiotechnologySEC FORM 4 Code M—67,489 at $0.00filing
17 Feb 2026filed 19 Feb 2026EOLS EvolusBiotechnologySEC FORM 4 Code A—313,212 at $0.00filing
17 Feb 2026filed 19 Feb 2026EOLS Evolusoption or derivative · BiotechnologySEC FORM 4 Code A—626,424 at $0.00filing
17 Feb 2026filed 19 Feb 2026EOLS Evolusoption or derivative · BiotechnologySEC FORM 4 Code A—457,541 at $0.00filing
17 Feb 2026filed 19 Feb 2026EOLS Evolusoption or derivative · BiotechnologySEC FORM 4 Code A—626,424 at $0.00filing
17 Feb 2026filed 19 Feb 2026EOLS Evolusoption or derivative · BiotechnologySEC FORM 4 Code A—457,541 at $0.00filing
17 Feb 2026filed 19 Feb 2026EOLS EvolusBiotechnologySEC FORM 4 Code A—313,212 at $0.00filing
22 Dec 2025filed 29 Dec 2025EOLS EvolusBiotechnologySEC FORM 4 Sold$75K10,539 at $7.15filing
12 Dec 2025filed 31 Dec 2025BMRA BiomericaDiagnostics & LabsSEC FORM 4 Code A—20,000 at $0.00filing

Sectors

Health Care31

Buys in green, sells in red, by the company’s sector.

Related people

Rui AvelarOfficer · Officer at Evolus, filing Form 4 there in the last year
Albert G. White IIIDirector · Director at Evolus, filing Form 4 there in the last year
David N. GillDirector · Director at Evolus, filing Form 4 there in the last year
Vikram MalikDirector · Director at Evolus, filing Form 4 there in the last year
Brady StewartDirector · Director at Evolus, filing Form 4 there in the last year
Allen BarbieriExecutive Vice Chairman · Also traded BMRA in the last 90 days
Eric ChinDirector · Also traded BMRA in the last 90 days
Zackary S. IraniChief Executive Officer · Also traded BMRA in the last 90 days